Intel's muted price action reflects a gloomy 1Q FY25 outlook, despite beating 4Q FY24 revenue and non-GAAP EPS estimates. See ...
Eli Lilly (LLY) stock rises as company posts Q4 2024 results, beating expectations with a twofold rise in revenue from weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback